Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference  

Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will participate in an analyst-led fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021, at 5:00 p.m. ET. The event will be accessible via a live webcast on the company's investor relations page, with a replay available for 90 days post-event. Wave Life Sciences focuses on developing innovative therapies for genetically defined diseases through its proprietary PRISM platform, aiming to create effective treatments and improve patient outcomes.

CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the virtual 10^th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 5:00 p.m. ET.

A live webcast of the presentation will be available on the investor relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

When is the Wave Life Sciences fireside chat scheduled?

The fireside chat for Wave Life Sciences is scheduled for February 25, 2021, at 5:00 p.m. ET.

Where can I watch the Wave Life Sciences presentation?

You can watch the presentation live on the investor relations page of Wave Life Sciences' website.

What is Wave Life Sciences' focus in the healthcare sector?

Wave Life Sciences is focused on developing life-changing genetic medicines for genetically defined diseases.

What is the PRISM platform used by Wave Life Sciences?

The PRISM platform is a proprietary technology used by Wave Life Sciences for the precise design and production of stereopure oligonucleotides.

How long will the replay of the Wave Life Sciences presentation be available?

The replay of the presentation will be available for 90 days after the event.